ReVivo Medical Raises Further Funds to Supprt Clinical Trial

ReVivo Medical completed its most recent equity offering, raising $1.3 million.

“We believe the funds raised will be sufficient to complete our clinical trial and petition the FDA for clearance of our next generation spinal implants,” explains
Gary Mittleman, President and CEO. “The $1.3 million of subscriptions came entirely from our current...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us